Coenzyme Q10 for Patients with Parkinson's Disease: A Systematic Review and Meta-Analysis.

@article{Negida2016CoenzymeQF,
  title={Coenzyme Q10 for Patients with Parkinson's Disease: A Systematic Review and Meta-Analysis.},
  author={Ahmed Negida and Ahmed Menshawy and Gehad Gamal El Ashal and Yasmin Elfouly and Yasmein Hani and Yasmin Hegazy and Samar El Ghonimy and Samar Fouda and Yomna Rashad},
  journal={CNS & neurological disorders drug targets},
  year={2016},
  volume={15 1},
  pages={45-53}
}
INTRODUCTION Coenzyme Q10 (CoQ10) is an antioxidant that enhances the activity of complex I and II in the Electron Transport Chain. Many preclinical and clinical studies evaluated CoQ10 for neuroprotection against Parkinson's disease (PD). The aim of this study is to synthesize evidence from published randomized controlled trials (RCTs) about the benefit of CoQ10 supplementation for patients with Parkinson's disease. METHODS We followed the PRISMA statement guidelines during the preparation… CONTINUE READING